MDS Nordion says Russia deal to supply key isotope
TORONTO, Sept 27 (Reuters) - A deal with Russia's Rosatom is expected to provide MDS Nordion with a key medical isotope for at least the next 10 years, but the move is not intended as a permanent replacement for supplies from an aging Canadian reactor, the company said on Monday.
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here